51
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A Survey On prevalence, Risk Factors and Knowledge for Oral Human Papillomavirus Infections Among University Students

ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 475-489 | Received 04 Oct 2020, Accepted 08 Jun 2021, Published online: 30 Jun 2021

References

  • Sanders AE , SladeGD, PattonLL. National prevalence of oral HPV infection and related risk factors in the U.S. adult population. Oral Dis., 18(5), 430–441 (2012).
  • Sugiyama M , BhawalUK, DohmenT, OnoS, MiyauchiM, IshikawaT. Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 95(5), 594–600 (2003).
  • Araldi RP , Sant’AnaTA, MódoloDGet al. The human papillomavirus (HPV)-related cancer biology: an overview. Biomed. Pharmacother., 106(April), 1537–1556 (2018).
  • Wagner S , RederH, SharmaSJ, WürdemannN, WittekindtC, KlußmannJP. HPV-associated oropharyngeal cancer-incidence, trends, diagnosis, and treatment. Urologe. A, 57(12), 1457–1463 (2018).
  • Rautava J , WillbergJ, LouvantoKet al. Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS ONE, 7(8), (2012).
  • Saeed M , FaisalSM, AkhtarFet al. Human papillomavirus induced cervical and oropharyngeal cancers: from mechanisms to potential immuno-therapeutic strategies. Curr. Drug Metab., 21(3), 167–177 (2020).
  • Egawa N , DoorbarJ. The low-risk papillomaviruses. Virus Res., 231, 119–127 (2017).
  • Cuberos V , PerezJ, JulianCet al. Molecular and serological evidence of the epidemiological association of HPV 13 with focal epithelial hyperplasia: a case–control study. 37(1), 21–26 (2006).
  • St Laurent J , LuckettR, FeldmanS. HPV vaccination and the effects on rates of HPV-related cancers. Curr. Probl. Cancer, 42(5), 493–506 (2018).
  • Pytynia KB , DahlstromKR, SturgisEM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol., 50(5), 380–386 (2014).
  • Syrjänen S . Oral manifestations of human papillomavirus infections. Eur. J. Oral Sci., 126, 49–66 (2018).
  • Woelber L , BreuerJ, MeyerTet al. Oral human papillomavirus in women with high-grade cervical intraepithelial neoplasia. J. Low. Genit. Tract Dis., 21(3), 177–183 (2017).
  • Owczarek K , Jalocha-KaczkaA, BielinskaM, UrbaniakJ, OlszewskiJ. Evaluation of risk factors for oral cavity and oropharynx cancers in patients under the week activity program of head and neck cancers prevention in Lodz. Otolaryngol. Pol., 69(6), 20–25 (2015).
  • Hearnden V , MurdochC, D’ApiceK, DuthieS, HaywardNJ, PowersHJ. Oral human papillomavirus infection in England and associated risk factors: a case–control study. BMJ Open, 8(8), 1–6 (2018).
  • Oliver SE , GorbachP, GratzerBet al. Risk factors for oral HPV infection among young men who have sex with men – 2 cities, United States, 2012–2014. Sex. Transm. Dis., 45(10), 660 (2018).
  • WHO . Human Papillomavirus Laboratory Manual. (2010). https://apps.who.int/iris/handle/10665/70505
  • Gravitt PE , PeytonCL, AppleRJ, WheelerCM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol., 36(10), 3020–3027 (1998).
  • Lupato V , HolzingerD, HöflerDet al. Prevalence and determinants of oral human papillomavirus infection in 500 young adults from Italy. PLoS ONE, 12(1), 1–13 (2017).
  • Antonsson A , CornfordM, PerryS, DavisM, DunneMP, WhitemanDC. Prevalence and risk factors for oral HPV infection in young Australians. PLoS ONE, 9(3), 1–7 (2014).
  • Winer RL , LeeS-K, HughesJP, AdamDE, KiviatNB, KoutskyLA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am. J. Epidemiol., 157(3), 218–226 (2003).
  • Mirghani H , BelleraC, DelayeJet al. Prevalence and characteristics of HPV-driven oropharyngeal cancer in France. Cancer Epidemiol., 61, 89–94 (2019).
  • Ang KK , HarrisJ, WheelerRet al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med., 363(1), 24–35 (2010).
  • Hang D , LiuF, LiuMet al. Oral human papillomavirus infection and its risk factors among 5,410 healthy adults in China, 2009-2011. Cancer Epidemiol. Biomarkers Prev., 23(10), 2101–2110 (2014).
  • Migaldi M , PecorariM, ForbiciniGet al. Low prevalence of human papillomavirus infection in the healthy oral mucosa of a northern Italian population. J. Oral Pathol. Med., 41(1), 16–20 (2012).
  • Lang Kuhs KA , GonzalezP, StruijkLet al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J. Infect. Dis., 208(10), 1643–1652 (2013).
  • Seifi S , AsvadiKermani I, DolatkhahRet al. Prevalence of oral human papilloma virus in healthy individuals in east Azerbaijan province of Iran. Iran. J. Public Health, 42(1), 79–85 (2013).
  • do Sacramento PR , BabetoE, ColomboJet al. The prevalence of human papillomavirus in the oropharynx in healthy individuals in a Brazilian population. J. Med. Virol., 78(5), 614–618 (2006).
  • Shigeishi H , SugiyamaM. Risk factors for oral human papillomavirus infection in healthy individuals: a systematic review and meta-analysis. J. Clin. Med. Res., 8(10), 721–729 (2016).
  • Marques M da PC , BussolotiFilho I, RossiLM, AndreoliMA, CruzNO. Comparative study between biopsy and brushing sampling methods for detection of human papillomavirus in oral and oropharyngeal cavity lesions. Braz. J. Otorhinolaryngol., 81(6), 598–603 (2015).
  • Moerman M , DanielidesVG, NousiaCS, Van WanzeeleF, ForsythR, VermeerschH. Recurrent focal epithelial hyperplasia due to HPV13 in an HIV-positive patient. Dermatology, 203(4), 339–341 (2001).
  • Johansson H , KravtchenkoE, ForslundO. Characterization of human papillomavirus subtype 72b. Genome Announc., 2(6), 4276 (2014).
  • Brown CR , LeonML, MuñozKet al. Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic. Brazilian J. Med. Biol. Res., 42(7), 629–636 (2009).
  • Kero K , RautavaJ. HPV Infections in heterosexual couples: mechanisms and covariates of virus transmission. Acta Cytol., 63(2), 143–147 (2019).
  • Harper DM , DemarsLR. Primary strategies for HPV infection and cervical cancer prevention. Clin. Obstet. Gynecol., 57(2), 256–278 (2014).
  • Giuliano AR , NyitrayAG, AlberoG. Male circumcision and HPV transmission to female partners. Lancet (London, England), 377(9761), 183–184 (2011).
  • Thorson A , RagnarssonA, RoslingH, EkströmAM. Male circumcision reduces HIV transmission. The risk of transmission from woman to man is halved. Lakartidningen, 107(46), 2881–2883 (2010).
  • Chaturvedi AK , GraubardBI, BroutianTet al. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the united States. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol., 36(3), 262–267 (2018).
  • Read TRH , HockingJS, VodstrcilLAet al. Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS ONE, 7(11) (2012).
  • Rajiah K , MaharajanMK, NumKSF, KohRCH. Knowledge about human papillomavirus and cervical cancer: predictors of HPV vaccination among dental students. Asian Pacific J. Cancer Prev., 18(6), 1573–1579 (2017).
  • Arora S , RamachandraSS, SquierC. Knowledge about human papillomavirus (HPV) related oral cancers among oral health professionals in university setting – a cross sectional study. J. Oral Biol. Craniofacial Res., 8(1), 35–39 (2018).
  • Sallam M , Al-FraihatE, DababsehDet al. Dental students’ awareness and attitudes toward HPV-related oral cancer: a cross sectional study at the University of Jordan. BMC Oral Health, 19(1), 171 (2019).
  • Rashid S , LabaniS, DasBC. Knowledge, awareness and attitude on HPV, HPV vaccine and cervical cancer among the college students in India. PLoS One, 11(11), e0166713 (2016).
  • Baloch Z , YasmeenN, LiYet al. Knowledge and awareness of cervical cancer, human papillomavirus (HPV), and HPV vaccine among HPV-infected Chinese women. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res., 23, 4269–4277 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.